Register of Therapeutical Patients Over 60 Years (ASCLEPIUS)

February 1, 2022 updated by: Tamara Kriukova, Eurasian Association of Therapists

Register on the Study of Prevalence and Incidence, Risk Factors and Outcomes of Hospitalizations in Older Age Groups in Eurasia.

Register for the study of the prevalence and burden of diseases, risk factors and outcomes of hospitalizations in older age groups in the countries of Eurasia.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

An open, multicenter registry to track all major noncommunicable diseases and risk factors in older age groups, prescribed drugs, and disease outcomes.

Study Type

Observational

Enrollment (Anticipated)

12000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Alexandra Deeva
  • Phone Number: +79033777940
  • Email: adeeva@euat.ru

Study Locations

  • Russian Federation
      • Moscow, Russian Federation, 101000
        • Eurasian Association of Therapists
        • Contact:
          • Tamara Kriukova
          • Phone Number: +79992114977
          • Email: tk@euat.ru
        • Contact:
          • Anastasia Rud
          • Phone Number: +79263639827
          • Email: rud@euat.ru

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Anonymous men and women in the age group over 60 see a doctor for any reason.

Description

Inclusion Criteria:

  • over 60 years
  • Appointment to a doctor of a therapeutic profile

Exclusion Criteria:

  • Reluctance of the Patient to participate in the Register;
  • Age under 60 at the time of inclusion in the Register.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence
Time Frame: 12 months
Incidence of non-infectious diseases
12 months
Non-infectious diseases
Time Frame: 12 months
Age-related non-infectious diseases dynamics of the development of the main after 60 years
12 months
Age groups
Time Frame: 12 months
The prevalence of various non-infectious diseases in different age groups
12 months
Therapy
Time Frame: 12 months
Names, doses and duration of prescribed therapy
12 months
Drugs
Time Frame: 12 months
Analysis of prescribed therapy and calculation of losses from improper treatment due to repeated hospitalizations, disability and complications
12 months
Measure criteria
Time Frame: 12 months
12000 patients
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Eurasian Association of Therapists

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

January 15, 2023

Primary Completion (Anticipated)

March 15, 2024

Study Completion (Anticipated)

March 15, 2024

Study Registration Dates

First Submitted

March 3, 2020

First Submitted That Met QC Criteria

March 3, 2020

First Posted (Actual)

March 4, 2020

Study Record Updates

Last Update Posted (Actual)

February 2, 2022

Last Update Submitted That Met QC Criteria

February 1, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EUAT
  • ASCLEPIUS (Registry Identifier: ASCLEPIUS)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Age Problem

Clinical Trials on Non-intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe